SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK946.68m
- SEK913.23m
- SEK200.23m
Brief: Sedana Medical Q4 Sales SEK 49.2 Million
Brief: Sedana Medical Gets Additional Year Of Market Protection For Sedaconda
Brief: Sedana Medical's U.S. Trial InspIre-ICU 1 Meets Primary Endpoint
Brief: Sedana Medical Raises Full-Year Guidance
Brief: Sedana Medical Q3 Sales SEK 39.7 Million
Brief: Sedana Medical Q2 Sales SEK 41.1 Million
Brief: Sedana Medical To Acquire Innovatif Cekal For Purchase Price Of 34 Mln SEK
Brief: Sedana Medical Q1 Sales SEK 48.8 Million
Brief: Sedana Medical May See Seasonally Lower Sales In Q2 And Q3
Brief: Sedana Medical Q4 Net Result at SEK -38.1 Million
Brief: Sedana Medical Gets Data Exclusivity, Market Protection For Sedaconda Until 2031
Brief: Sedana Medical Q3 EBITDA at SEK -12.6 Million
Brief: Sedana Medical Gets Market Approval In The UK
Brief: Sedana Medical Gets US Patent For Sedaconda Acd-S
Brief: Sedana CEO And CFO Acquire 100,000 Shares In Company Each
Brief: Sedana Medical Q2 EBIT Margin at -44%
Brief: Sedana Medical - Will Provide Short-Term Financial Targets
Brief: Sedana Medical Informs About Adjusted US Submission Plan Following FDA Interaction
Brief: Sedana Medical Reports Topline Results From Phase 3 Study